Vimarsana
Biggest News Aggregation in the World

Page 3 - James Pan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James Pan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Pan Today - Breaking & Trending Today

Federal Judge Rules Virginia Race-Based Admissions Is Discriminatory - Vimarsana News

Federal Judge Rules Virginia Race-Based Admissions Is Discriminatory

A federal judge ruled that admissions changes at a public high school, which were put in place to pursue "equity," are discriminatory.

Global exhibitors choose Intertextile as key business trading platform - Vimarsana News

Global exhibitors choose Intertextile as key business trading platform

Optimal results were observed at the Intertextile Shanghai Apparel Fabric's autumn edition as more international exhibitors chose the platform as their key business trading...

4x Nebraska High School State Champ Kael Mlinek Verbally Commits to Princeton - Vimarsana News

4x Nebraska High School State Champ Kael Mlinek Verbally Commits to Princeton

Summer Juniors qualifier Kael Mlinek has announced his intention to swim at Princeton beginning in the fall of 2022.

NAG Relay Record-holder Mitchell Schott Makes Verbal Commitment to Princeton - Vimarsana News

NAG Relay Record-holder Mitchell Schott Makes Verbal Commitment to Princeton

Summer Juniors qualifier Mitchell Schott has announced his intention to swim at Princeton University beginning in the fall of 2022.

Exacis Biotherapeutics Presents Data on its Stealth mRNA-Engineered NK-cell Platform at American Society of Gene & Cell Therapy Annual Meeting - Vimarsana News

Exacis Biotherapeutics Presents Data on its Stealth mRNA-Engineered NK-cell Platform at American Society of Gene & Cell Therapy Annual Meeting

Share this article Share this article CAMBRIDGE, Mass., May 25, 2021 /PRNewswire/ -- Exacis Biotherapeutics Inc., a development-stage immuno-oncology company working to democratize access to the most advanced and effective cancer treatments, revealed key data related to its engineered iPSC-derived NK-cell platform at the American Society of Gene & Cell Therapy 24th Annual Meeting. These data include the successful generation of functional NK cells from iPSCs engineered to contain a biallelic knockout of a key MHC class I gene. Exacis' cell engineering strategy is designed to allow its E...